Case: Growth on pancreas shows estrogen link to pancreatic cancer
Changes in how cells respond to the hormone estrogen may underlie the development of certain forms of pancreatic cancer. That’s according to findings from…
Pancreatic cancer
Camera pill to find pancreatic cancer seeks breakthrough status
Capsovision is requesting that the U.S. Food and Drug Administration (FDA) expedite the development of its CapsoCam UGI capsule endoscopy system as…
FDA speeds development of oral pancreatic cancer treatment
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to daraxonrasib, an oral therapy being developed by Revolution Medicines to treat…
November shines a spotlight on pancreatic cancer awareness
November is Pancreatic Cancer Awareness Month, and advocates nationwide are hosting events to unite the community and raise awareness about the condition. For this year’s…
Tango plans pivotal trial of vopimetostat for pancreatic cancer
Following new, positive data from a Phase 1/2 clinical study, Tango Therapeutics is planning to launch a pivotal trial to test its therapy candidate…
Treatment extends pancreatic cancer survival to 2 years: Trial data
Six of 10 pancreatic cancer patients treated with the investigational drug certepetide along with chemotherapy prior to surgery were alive two years later, according…
All main goals hit in trial testing AlphaMedix for pancreatic cancer
A Phase 2 clinical trial testing Sanofi‘s therapy candidate AlphaMedix (212Pb-DOTAMTATE) in people with a certain type of pancreatic cancer has hit all its…
Utidelone now FDA orphan drug after promising cancer trial results
Biostar Pharma’s experimental therapy utidelone has been granted orphan drug status for pancreatic cancer by the U.S. Food and Drug Administration (FDA). The…
Atebimetinib yields ‘extraordinary’ results in pancreatic cancer trial
An experimental cancer therapy known as atebimetinib is delivering “extraordinary” results for patients with pancreatic cancer. New data from an ongoing Phase 2a clinical…
New blood test detects multiple cancers at early stages
A new blood test capable of detecting multiple cancers at earlier, more treatable stages is now available in the U.S. for $689, its developer said.
